Elutia ELUT
NASDAQ ELUT
$0.78 -0.02 (-2.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Elutia (ELUT) Gains from Sales and Divestitures (2026)

Updated

Elutia's Gains from Sales and Divestitures came in at $425,000 for Q1 2026.

Analysis

Elutia (ELUT) Gains from Sales and Divestitures (2026) Analysis & Trends

For FY2025, Elutia's Gains from Sales and Divestitures was $80.21 million.

  • Going back by year, Gains from Sales and Divestitures was $180,000 in FY2024 (-97.6%) and $7.53 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Elutia 34.55 Mn -54.91 Mn 1.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 425,000.00
API Access

Elutia Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ELUT&period=max&api_key=YOUR_API_KEY